Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.49 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.49 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.49 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16009093 | 0.87 | HDAC3 (0.48) | FFAR1HDAC3MAPK1TDP1NPC1 | |
| SCHEMBL114130 | 0.86 | HDAC1 (0.64) | FFAR1SMN1; SMN2HDAC3HDAC4HDAC1 | |
| SCHEMBL4666437 | 0.86 | HDAC1 (0.64) | FFAR1SMN1; SMN2HDAC3HDAC4HDAC1 | |
| SCHEMBL1572987 | 0.86 | EPHX2 (0.46) | LMNASMN1; SMN2 | |
| SCHEMBL721274 | 0.85 | EPHX2 (0.48) | LMNASMN1; SMN2TDP1FAAH | |
| SCHEMBL10897829 | 0.85 | LMNA (0.51) | LMNAFFAR1SMN1; SMN2HDAC3HDAC4 | |
| SCHEMBL443150 | 0.84 | MAPT (0.63) | SMN1; SMN2HDAC3HDAC4HDAC1HDAC7 | |
| Hydrochloric Acid SCHEMBL11273048 | 0.84 | HDAC1 (0.62) | FFAR1SMN1; SMN2HDAC3HDAC4HDAC1 | |
| SCHEMBL9565754 | 0.83 | TDP1 (0.49) | LMNAFFAR1SMN1; SMN2HDAC3HDAC4 | |
| SCHEMBL8971314 | 0.83 | MAPT (0.67) | SMN1; SMN2HDAC3HDAC4HDAC1HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2535379-B1 | Ink set and image forming method | FUJIFILM CORP (JP) | 2018-05-16 | — | — | EP | disclosed |
| EP-2902212-B1 | IMAGE FORMATION METHOD | FUJIFILM CORP (JP) | 2017-09-06 | — | — | EP | disclosed |
| US-9517635-B2 | Image forming method | FUJIFILM CORPORATION (JP) | 2016-12-13 | — | — | US | disclosed |
| EP-2902212-A1 | IMAGE FORMATION METHOD | FUJIFILM Corporation (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-20150166819-A1 | IMAGE FORMING METHOD | FUJIFILM CORPORATION (JP) | 2015-06-18 | — | — | US | disclosed |
| US-20120320123-A1 | INK SET AND IMAGE FORMING METHOD | FUJIFILM CORPORATION (JP) | 2012-12-20 | — | — | US | disclosed |
| EP-2535379-A1 | Ink set and image forming method | Fujifilm Corporation (JP) | 2012-12-19 | — | — | EP | disclosed |
| US-7847888-B2 | Liquid crystal display device including protective films having predetermined moisture permeability characteristics | FUJIFILM CORPORATION (JP) | 2010-12-07 | — | — | US | disclosed |
| US-20080218666-A1 | Liquid crystal display device | FUJIFILM CORPORATION (JP) | 2008-09-11 | — | — | US | disclosed |
| US-7025816-B2 | Anthraquinone dye and inkjet recording liquid | KONICA MINOLTA HOLDINGS, INC. (JP) | 2006-04-11 | — | — | US | disclosed |
| US-20050103226-A1 | Anthraquinone dye and inkjet recording liquid | KONICA MINOLTA HOLDINGS, INC. (JP) | 2005-05-19 | — | — | US | disclosed |
| US-6340562-B1 | HIGH SENSITIVITY, LOW FOG AND EXCELLENT PRESSURE RESISTANCE | KONICA CORPORATION (JP) | 2002-01-22 | — | — | US | disclosed |
| US-5455148-A | Interfacial polymerization of acrylic acid and ester monomers and copolymer in aqueous and particle phases; curl resistance | POLAROID CORPORATION (US) | 1995-10-03 | — | — | US | disclosed |
| EP-0394791-B1 | Photographic material having an antistatic layer | AGFA GEVAERT AG (DE) | 1995-09-06 | — | — | EP | disclosed |
| EP-0332165-A2 | Silver halide color reversal photographic light-sensitive material | Fuji Photo Film Co., Ltd. (JP) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050103226-A1 | Anthraquinone dye and inkjet recording liquid | MLLT3, GNPAT, IK | LMNA 2299/4885FFAR1 4661/4885SMN1; SMN2 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.